Under construction – not a live service

Skip to content

Frontlight Research

Trial site

Uppsala

Uppsala, SwedenNot linked to an institution yet

3running trials
4closed trials
0trials confirmed by the site in the last 60 days
–languages not stated

The site has not confirmed any trial yet.

Running trials

Active, not recruiting
A Study of Apalutamide (JNJ-56021927, ARN-509) Plus Androgen Deprivation Therapy (ADT) Versus ADT in Participants With mHSPC
NCT02489318· Phase 3· Source
Active, not recruiting
A Study of Two Different Doses of Cabozantinib (XL184) in Progressive, Metastatic Medullary Thyroid Cancer
NCT01896479· Phase 4· Source
Active, not recruiting
A Study of Apalutamide (ARN-509) in Men With Non-Metastatic Castration-Resistant Prostate Cancer
NCT01946204· Phase 3· Source

Researchers

No researcher is linked here yet.

Closed trials

Completed
Addition of Daratumumab to Combination of Bortezomib and Dexamethasone in Participants With Relapsed or Refractory Multiple Myeloma
NCT02136134· Phase 3· Source
Completed
A Study Comparing Daratumumab, Lenalidomide, and Dexamethasone With Lenalidomide and Dexamethasone in Relapsed or Refractory Multiple Myeloma
NCT02076009· Phase 3· Source
Completed
A Study of the Bruton's Tyrosine Kinase Inhibitor Ibrutinib Given in Combination With Bendamustine and Rituximab in Patients With Newly Diagnosed Mantle Cell Lymphoma
NCT01776840· Phase 3· Source
Recruiting
Product Performance Report: Evaluate Long-term Reliability & Performance of Medtronic Marketed Cardiac Therapy Products
NCT00271180· Source

Site data: ClinicalTrials.govUpdated 6 Nov 2026

Report an error